Showing results (101-110 of 443) with videos related to

Sort By:
Pageof 45
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|October 18, 2016
Phenomenology of COPD: interpreting phenotypes with the ECLIPSE studyAlberto Papi, Maria Sandra Magnoni, Carmelo Caio Muzzio, et al.
Multidisciplinary Respiratory Medicine|September 18, 2024
An Italian Delphi Consensus on the Triple inhalation Therapy in Chronic Obstructive Pulmonary DiseasePaolo Solidoro, Federico Dente, Claudio Micheletto, et al.
Pathogens (Basel, Switzerland)|November 24, 2022
SARS-CoV-2 Infection Prompts IL-1β-Mediated Inflammation and Reduces IFN-λ Expression in Human Lung TissueBianca Vezzani, Margherita Neri, Stefano D'Errico, et al.
Current Drug Targets|December 22, 2012
Immune and genetic mechanisms in COPD: possible targets for therapeutic interventionsEleni G Tzortzaki, Alberto Papi, Eirini Neofytou, et al.
Respiratory Medicine|August 7, 2013
Stepping down from high dose fluticasone/salmeterol to extrafine BDP/F in asthma is cost-effectivePierluigi Paggiaro, Shishir Patel, Gabriele Nicolini, et al.
The Journal of Allergy and Clinical Immunology|April 3, 2007
Demographic and clinical characteristics of children and adolescents with severe or difficult-to-treat asthmaBradley E Chipps, Stanley J Szefler, F Estelle R Simons, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 2, 2018
Racial Disparities in Asthma-Related Health Outcomes in Children with Severe/Difficult-to-Treat AsthmaTheresa Guilbert, Robert S Zeiger, Tmirah Haselkorn, et al.
The Journal of Pediatrics|May 2, 2006
Variability in asthma severity in pediatric subjects with asthma previously receiving short-acting beta2-agonistsBradley E Chipps, Joseph D Spahn, Christine A Sorkness, et al.
The Journal of Allergy and Clinical Immunology|November 10, 2016
A randomized multicenter study evaluating Xolair persistence of response after long-term therapyDennis Ledford, William Busse, Benjamin Trzaskoma, et al.
Frontiers in Pharmacology|December 10, 2021
Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary DiseaseFabrizio Facchinetti, Maurizio Civelli, Dave Singh, et al.
Pageof 45